Crizotinib Rudiments Defined

Матеріал з HistoryPedia
Версія від 07:24, 21 червня 2017, створена Burst58alto (обговореннявнесок) (Створена сторінка: �� Of course, when CFA can confirm results of EFA on the same data, one can only expect, but cannot make sure, that CFA will confirm results of EFA in a dif...)

(різн.) ← Попередня версія • Поточна версія (різн.) • Новіша версія → (різн.)
Перейти до: навігація, пошук

�� Of course, when CFA can confirm results of EFA on the same data, one can only expect, but cannot make sure, that CFA will confirm results of EFA in a different sample or population. For these reason, random samples were also used to perform EFA and then to test the CFA using unseen data. Note that the CFA was undertaken using (a) all data, (b) the clinical subsample, (c) the community sample, and (d) following Gerbing & Hamilton (1996) random samples of size n = 500 were used to perform EFA and with the remainder to test the CFA model. In all cases, the same ICM-CFA model was tested. The data from participants was randomly split into two mutually exclusive subsamples. One subsample (n = 504) was used for EFA, and the other subsample was used for CFA (n = 509) for R428 the discovered model. Throughout, learn more standard measures of fit in CFA, including the root mean squared error approximation (RMSEA), minimum discrepancy per degree of freedom (CMIN/DF), goodness-of-fit index (GFI), adjusted goodness-of-fit index (AGFI), normed fit index (NFI), non-normed fit index (NNFI), and comparative fit index (CFI). In general threshold values of less than 0.01, 0.05, 0.08 for RMSEA are indicative of excellent, good and mediocre fit (see MacCallum, Browne & Sugawara, 1996) and with RMSEA > 0.1 indicating a poorly specified model. CMIN/DF UGT1A7 NFI, CFI and NNFI > 0.9 indicate good levels of fit between data and model with more liberal criteria of 0.85